Desai KB, Serritella AV, Stadler WM, O'Donnell PH, et al. A phase I trial of enzalutamide plus selective glucocorticoid receptor modulator relacorilant in patients with metastatic castration resistant prostate cancer. Clin Cancer Res 2024 Mar 27. doi: 10.1158/1078-0432.CCR-23-3636.
PMID: 38536082